(P-594) Temperature Stability of BPL-1357, a BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Camellia Banerjee, MD, PhD (she/her/hers)

Clinical Fellow
National Institutes of Health
Bethesda, Maryland, United States

Luca Tudor Giurgea, MD

Assistant Research Physician
National Institute of Allergy and Infectious Diseases
Bethesda, MD, United States
AC

Adriana Cervantes-Medina, BS

Technician
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
JT

Jeffery Taubenberger, MD, PhD

Senior Investigator
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
Matthew J. Memoli, MD, MS

Senior Clinician, Director LID Clinical Studies Unit
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States